Meld Criteria in the Transplant Waiting List: Impact on Mortality Overall and by Diagnostic Groups
The modification of liver graft allocation for selection by severity criteria based on the Model for End-Stage Liver Disease (Meld) has not yet been properly analyzed in Brazil regarding the distribution of indications for transplant and mortality among enrolled patients. In a context of low organ donation and procurement, this assessment is relevant. Objective: To compare mortality on the liver transplant waiting list in Brazil before and after the adoption of Meld score as a criterion for allocation on the waiting list: overall, by diagnostic group, and by Meld range at enrollment. Methods: We retrospectively studied 899 patients (median age = 52.8 years, body mass index, BMI = 25.2 and Meld = 18) divided into the pre- (n = 320, 35.6%) and post-Meld (n = 579, 64.4%) periods and into groups: 1 (n = 480, 53.4%): ethanolic, cryptogenic and autoimmune cirrhosis; 2 (n = 80, 8.9%): biliary diseases; 3 (n = 93, 10.3%): metabolic and other diseases; and 4 (n = 246, 27.4%): post-viral B and C cirrhosis. Special scoring was assigned to 19.5% of patients, according to legislation criteria. The sample was also divided by Meld ranges at enrollment (< 18; 18–24; and < 24). Waitlist mortalities of the pre- and post-Meld groups were compared in the total sample, in each diagnostic group, and in each Meld range. Results: The incidence of referrals to transplantation was different in the pre- and post-Meld eras (p = 0.049), increasing in group 3 (from 8.1 to 11.6%) and decreasing in group 4 (from 32.5 to 24.5%). Of the enrollees, 32.9% died before transplantation. Mean Meld increased from 16 to 20 (p < 0.001), and mean time between enrollment and outcome (transplant or death) decreased from 102 days to 58 (p = 0.028). Waiting list mortality dropped from 105.7% (patient-years) to 54.9% in the post-Meld group (p = 0.001). There was a reduction from 104.2% (patientyears) to 51.1% (p = 0.034) in group 1, and the proportion fell from 160.3% (patient-years) to 52% (p = 0.019) in group 2. On the other hand, there was no statistically significant variation in the groups 3 and 4. In Meld range 1 (< 18), mortality ranged from 87.2% per patient-year to 24.1% per patientyear (p = 0.005). In Meld range 2 (18–24), it ranged from 109.8 to 72.4% per patient-year (p = 0.019). In the Meld < 24 range, there was no significant change in waitlist mortality. Finally, survival at 1, 3 and 12 months after transplantation did not vary significantly between the pre-Meld and postMeld era. Conclusion: Comparing the pre- and post-Meld groups, patients were enrolled when they were most severely ill, and there was a reduction in mean time on the list for the outcome and a decrease in waiting list mortality with no change in post-transplant survival. Diagnosis groups 1 and 2 have benefited. In addition, the decrease in waiting list mortality was observed among patients with Meld < 24 at the time of enrollment. This reduction was not observed in the group of patients with Meld < 24.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Brazilian Journal of Transplantation - 25(2022), 2, Seite e0722-e0722 |
Sprache: |
Englisch ; Spanisch ; Portugiesisch |
---|
Beteiligte Personen: |
Caio Ribeiro Melki [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Liver |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
DOAJ036746657 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ036746657 | ||
003 | DE-627 | ||
005 | 20230307233133.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ036746657 | ||
035 | |a (DE-599)DOAJ763179df6b3a436582576f6a9f62ccf9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a spa |a por | ||
050 | 0 | |a RC581-951 | |
050 | 0 | |a RC952-1245 | |
050 | 0 | |a RD1-811 | |
100 | 0 | |a Caio Ribeiro Melki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Meld Criteria in the Transplant Waiting List: Impact on Mortality Overall and by Diagnostic Groups |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The modification of liver graft allocation for selection by severity criteria based on the Model for End-Stage Liver Disease (Meld) has not yet been properly analyzed in Brazil regarding the distribution of indications for transplant and mortality among enrolled patients. In a context of low organ donation and procurement, this assessment is relevant. Objective: To compare mortality on the liver transplant waiting list in Brazil before and after the adoption of Meld score as a criterion for allocation on the waiting list: overall, by diagnostic group, and by Meld range at enrollment. Methods: We retrospectively studied 899 patients (median age = 52.8 years, body mass index, BMI = 25.2 and Meld = 18) divided into the pre- (n = 320, 35.6%) and post-Meld (n = 579, 64.4%) periods and into groups: 1 (n = 480, 53.4%): ethanolic, cryptogenic and autoimmune cirrhosis; 2 (n = 80, 8.9%): biliary diseases; 3 (n = 93, 10.3%): metabolic and other diseases; and 4 (n = 246, 27.4%): post-viral B and C cirrhosis. Special scoring was assigned to 19.5% of patients, according to legislation criteria. The sample was also divided by Meld ranges at enrollment (< 18; 18–24; and < 24). Waitlist mortalities of the pre- and post-Meld groups were compared in the total sample, in each diagnostic group, and in each Meld range. Results: The incidence of referrals to transplantation was different in the pre- and post-Meld eras (p = 0.049), increasing in group 3 (from 8.1 to 11.6%) and decreasing in group 4 (from 32.5 to 24.5%). Of the enrollees, 32.9% died before transplantation. Mean Meld increased from 16 to 20 (p < 0.001), and mean time between enrollment and outcome (transplant or death) decreased from 102 days to 58 (p = 0.028). Waiting list mortality dropped from 105.7% (patient-years) to 54.9% in the post-Meld group (p = 0.001). There was a reduction from 104.2% (patientyears) to 51.1% (p = 0.034) in group 1, and the proportion fell from 160.3% (patient-years) to 52% (p = 0.019) in group 2. On the other hand, there was no statistically significant variation in the groups 3 and 4. In Meld range 1 (< 18), mortality ranged from 87.2% per patient-year to 24.1% per patientyear (p = 0.005). In Meld range 2 (18–24), it ranged from 109.8 to 72.4% per patient-year (p = 0.019). In the Meld < 24 range, there was no significant change in waitlist mortality. Finally, survival at 1, 3 and 12 months after transplantation did not vary significantly between the pre-Meld and postMeld era. Conclusion: Comparing the pre- and post-Meld groups, patients were enrolled when they were most severely ill, and there was a reduction in mean time on the list for the outcome and a decrease in waiting list mortality with no change in post-transplant survival. Diagnosis groups 1 and 2 have benefited. In addition, the decrease in waiting list mortality was observed among patients with Meld < 24 at the time of enrollment. This reduction was not observed in the group of patients with Meld < 24 | ||
650 | 4 | |a organ transplantation | |
650 | 4 | |a liver transplantation | |
650 | 4 | |a liver | |
653 | 0 | |a Specialties of internal medicine | |
653 | 0 | |a Special situations and conditions | |
653 | 0 | |a Surgery | |
700 | 0 | |a João Lucas Ribeiro e Fernandes |e verfasserin |4 aut | |
700 | 0 | |a Agnaldo Soares Lima |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Brazilian Journal of Transplantation |d Associação Brasileira de Transplante de Órgãos, 2022 |g 25(2022), 2, Seite e0722-e0722 |w (DE-627)DOAJ00014729X |x 27641589 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2022 |g number:2 |g pages:e0722-e0722 |
856 | 4 | 0 | |u https://doi.org/10.53855/bjt.v25i2.454_en |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/763179df6b3a436582576f6a9f62ccf9 |z kostenfrei |
856 | 4 | 0 | |u https://bjt.emnuvens.com.br/revista/article/view/454 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2764-1589 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 25 |j 2022 |e 2 |h e0722-e0722 |